Search research articles
Contact Us
Filters
Showing results (281-290 of 316) with videos related to
Page
of 32
Sort By:
British Journal of Cancer
|
July 17, 2020
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer
Vincenza Conteduca, Daniel Wetterskog, Emanuela Scarpi, et al.
Respiration; International Review of Thoracic Diseases
|
March 2, 2016
Safety and Diagnostic Yield of Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Diseases: A Comparative Study versus Video-Assisted Thoracoscopic Lung Biopsy and a Systematic Review of the Literature
Claudia Ravaglia, Martina Bonifazi, Athol U Wells, et al.
The Oncologist
|
May 16, 2025
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer
Vincenza Conteduca, Emanuela Scarpi, Alice Rossi, et al.
International Journal of Cancer
|
October 4, 2021
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients
Vincenza Conteduca, Emanuela Scarpi, Daniel Wetterskog, et al.
Scientific Reports
|
July 2, 2025
Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA
Alessandra Virga, Milena Urbini, Maurizio Polano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2026
Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy
Milena Urbini, Thomas F Eleveld, Maurizio Polano, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
November 15, 2017
High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment
E Parisi, A Romeo, A Sarnelli, et al.
ESMO Open
|
April 25, 2025
Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial
G Schepisi, M Urbini, C Casadei, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 2, 2021
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study
Vincenza Conteduca, Daniel Wetterskog, Elena Castro, et al.
Bulletin of Volcanology
|
March 7, 2022
Analysis of the 2020 Taal Volcano tephra fall deposits from crowdsourced information and field data
M I R Balangue-Tarriela, A M F Lagmay, D M Sarmiento, et al.
Page
of 32
Search research articles
Search
Showing results (281-290 of 316) with videos related to
Sort By:
Page
of 32
British Journal of Cancer
|
July 17, 2020
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer
Vincenza Conteduca, Daniel Wetterskog, Emanuela Scarpi, et al.
Respiration; International Review of Thoracic Diseases
|
March 2, 2016
Safety and Diagnostic Yield of Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Diseases: A Comparative Study versus Video-Assisted Thoracoscopic Lung Biopsy and a Systematic Review of the Literature
Claudia Ravaglia, Martina Bonifazi, Athol U Wells, et al.
The Oncologist
|
May 16, 2025
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer
Vincenza Conteduca, Emanuela Scarpi, Alice Rossi, et al.
International Journal of Cancer
|
October 4, 2021
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients
Vincenza Conteduca, Emanuela Scarpi, Daniel Wetterskog, et al.
Scientific Reports
|
July 2, 2025
Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA
Alessandra Virga, Milena Urbini, Maurizio Polano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2026
Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy
Milena Urbini, Thomas F Eleveld, Maurizio Polano, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
November 15, 2017
High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment
E Parisi, A Romeo, A Sarnelli, et al.
ESMO Open
|
April 25, 2025
Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial
G Schepisi, M Urbini, C Casadei, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 2, 2021
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study
Vincenza Conteduca, Daniel Wetterskog, Elena Castro, et al.
Bulletin of Volcanology
|
March 7, 2022
Analysis of the 2020 Taal Volcano tephra fall deposits from crowdsourced information and field data
M I R Balangue-Tarriela, A M F Lagmay, D M Sarmiento, et al.
Page
of 32